Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02313623 · ClinicalTrials.gov registry record
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 600
- Enrollment target
NCT02313623 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 600 participants.
The verdict
NCT02313623 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. These profiles will in turn enable better predictions of the malignant progression of prostate cancers in the settings of current clinical practice.
Interventions
- PROCEDURE Prostate Fusion Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2013-07 |
| Est. Completion | 2025-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02313623
The ClinicalTrials.gov registry entry for NCT02313623 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prostate Fusion Biopsy is the first listed.
NCT02313623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02313623 about?
NCT02313623 is a clinical study titled "MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research". The investigators hypothesize that this single-cell analysis can be used to evaluate prostate needle-core biopsies prospectively even in non-homogenous samples by providing profiles of proteomic and phenotypic signatures. These profiles will in turn enable better predictions of the malignant progres...
What is the current status of trial NCT02313623?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2013-07. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT02313623?
The interventions under investigation include: Prostate Fusion Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT02313623?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.